New Strategies for the Treatment of Pulmonary Hypertension in Sickle Cell Disease: The Rationale for Arginine Therapy

ISSN： 1176-3450

Source： Treatments in Respiratory Medicine, Vol.5, Iss.1, 2006-01, pp. : 31-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pulmonary Hypertension Associated with Sickle Cell Disease: Pathophysiology and Rationale for Treatment

By Benza Raymond

Lung, Vol. 186, Iss. 4, 2008-08 ,pp. : 247-254

Springer Publishing Company

Access to resources Recommend Favorite

Hemolysis-Associated Pulmonary Hypertension in Sickle Cell Disease: Global Disruption of the Arginine-Nitric Oxide Pathway

Current Hypertension Reviews, Vol. 3, Iss. 3, 2007-08 ,pp. : 223-230

Bentham Science Publishers

Access to resources Recommend Favorite

High Prevalence of Pulmonary Hypertension in Homozygous Sickle Cell Patients with Leg Ulceration

By Serarslan Gamze Akgul Ferit Babayigit Cenk

Clinical and Experimental Hypertension, Vol. 31, Iss. 1, 2009-02 ,pp. : 44-48

Informa Healthcare

Access to resources Recommend Favorite

What's New in the Pathophysiology of Sickle Cell Disease?

Medical Principles and Practice, Vol. 22, Iss. 4, 2013-04 ,pp. : 311-312

Karger

Access to resources Recommend Favorite

New Strategies and Drugs in the Treatment of Hypertension: Monotherapy or Combination?

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 69-81

Bentham Science Publishers

Access to resources Recommend Favorite